ASO Author Reflections: PSMA PET in the Prostate Cancer Primary Staging Scenario—A Reliable Method with a Remarkable Decision-Making Impact

Abstract Prostate cancer (PCa) is the second most common malignant tumor in men in Brazil and worldwide. Although positron emission tomography (PET) prostate-specific membrane antigen (PSMA) has been used for over 10 years and several studies have been published regarding its superior performance in PCa primary staging and other scenarios, the management decision is often still based on conventional imaging information. A retrospective analysis was performed in 35 patients with PCa in the primary staging scenario with conventional exams as well as with PET PSMA. The findings of our study showed changes on the staging classification and significant impact on the therapeutic choice. PET PSMA is a dependable imaging exam and has already proved its worth and superiority when compared with conventional methods to evaluate PCa patients in primary staging and biochemical relapse, in addition to other potential roles. Prospective studies are needed to assess the outcome of patients whose management was guided by PSMA..

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Annals of surgical oncology - 30(2023), 7 vom: 03. Apr., Seite 4550-4551

Sprache:

Englisch

Beteiligte Personen:

da Silva, Anna Carolina Borges [VerfasserIn]
de Toledo, Luís Gustavo Morato [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Anmerkungen:

© Society of Surgical Oncology 2023

doi:

10.1245/s10434-023-13426-2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2143760043

Zugang & Verfügbarkeit




Zugehörige Publikationen/Bände

    Haven't found what you're looking for?